MedMira Announces CFO Departure

About this update from Medmira Inc.

[{"type":"text","content":"\n\n\nHALIFAX, Dec. 2, 2013 /CNW/ - MedMira, Inc. (MedMira) (TSXV: MIR), a\n developer of rapid diagnostic technology and solutions, today announced\n that Dan Frid, the Company's Chief Financial Officer, will leave the\n Company effective December 6, 2013, to pursue other professional\n opportunities.  Frid has served as MedMira's CFO since July 2010, with\n overall responsibility for financial and accounting operations,\n strategic fiscal planning, accountability and analysis, and contributed\n to various corporate support and administrative functions.\n\n\n\"We would like to thank Dan for his leadership and contributions to the\n Company,\" said Hermes Chan, Chief Executive Officer of MedMira Inc.\n \"Dan has been committed to this organization and has added to the\n strength of its financial position.  We wish him all the best in his\n future endeavours.\"\n\n\nThe Company has identified a new CFO and a detailed announcement will be\n issued shortly.\n\n\nAbout MedMira\n\n\nMedMira is the leading developer and manufacturer of flow-through rapid\n diagnostics and technologies. MedMira is the only Canadian company to\n be awarded US Army contracts for the development of rapid tests for HIV\n and Hepatitis viruses.  The Company's testing solutions provide\n hospitals, labs, clinics and individuals with reliable, rapid diagnosis\n for diseases such as HIV and hepatitis C in just three minutes. The\n Company's tests are sold under the Reveal®, Multiplo™ and Miriad brands\n in global markets. MedMira is located in Halifax, Nova Scotia, Canada. www.medmira.com.\n\n\nThis news release contains forward-looking statements, including\n statements relating to growth in the Company's business, earnings and\n profitability, and trends in demand for the Company's products, which\n involve risk and uncertainties and reflect the Company's current\n expectation regarding future events including statements regarding\n possible future growth and new business opportunities.  Actual events\n could materially differ from those projected herein and depend on a\n number of factors including, but not limited to, changing market\n conditions, successful and timely completion of clinical studies,\n uncertainties related to the regulatory approval process, establishment\n of corporate alliances and other risks detailed fr...

More updates from Medmira Inc.